U.S., Dec. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07265778) titled 'Clinical Investigation for Evaluating the Safety and Efficacy of JTM102 to Mid Face Volume Deficiency' on Nov. 24.

Brief Summary: This study is clinical investigation for evaluating safety and efficacy of JTM102 on temporary correction of mid-face volume deficiency

Study Start Date: Oct. 22, 2024

Study Type: INTERVENTIONAL

Condition: Mid Face Volume Deficit

Intervention: DEVICE: JTM102

Sodium Hyaluronate 20mg/ml Lidocaine Hydrochloride 03.%

DEVICE: Juvederm VOLUMA with Lidocaine

Sodium Hyaluronate 20mg/ml Lidocaine Hydrochloride 0.3%

Recruitment Status: ACTIVE_NOT_RECRUITING

Sponsor: Jetema Co., Ltd.

Disclaimer: Curated b...